Keyphrases
Acetaminophen
13%
Acute Liver Failure
68%
Allograft
11%
Alpha-fetoprotein
7%
Antiretroviral Therapy
7%
Autoimmune Hepatitis
7%
Bone Disease
7%
CD4+
7%
Cholestatic Liver Disease
13%
Chronic Hepatitis C
26%
Chronic Liver Disease
7%
Cirrhosis
22%
Cirrhotic Liver
7%
Clinical Outcomes
7%
End-stage Liver Disease
10%
Etiology
17%
Fibrosis
13%
Graft Survival
10%
Hepatitis
9%
Hepatitis B Virus
10%
Hepatitis C
28%
Hepatitis C Recurrence
7%
Hepatitis C Virus
47%
Hepatitis C Virus Infection
7%
Hepatocellular Carcinoma
26%
Immune Response
8%
Immunosuppression
11%
Infected Patients
8%
Interferon-α (IFN-α)
24%
Liver
18%
Liver Allograft
9%
Liver Disease
8%
Liver Transplant Recipients
40%
Liver Transplantation
100%
MELD Score
13%
MicroRNA
10%
Orthotopic Liver Transplantation
38%
Patient Survival
17%
Pretransplant
13%
Primary Biliary Cirrhosis
18%
Primary Sclerosing Cholangitis
15%
Prognostic Model
7%
Recurrent Hepatitis
8%
Ribavirin
15%
Risk Factors
9%
Solid Organ Transplantation
7%
Survival Rate
8%
Transplantation
28%
United States
13%
Virus-specific
12%
Medicine and Dentistry
Acute Liver Failure
49%
Allograft
18%
Alpha-Fetoprotein
7%
Antiviral Drug
6%
Antiviral Therapy
6%
Biopsy Technique
6%
Bone Density
6%
Bone Disease
7%
Chronic Hepatitis C
10%
Chronic Liver Disease
6%
Cohort Analysis
6%
Combination Therapy
6%
Diseases
25%
End Stage Liver Disease
10%
Fibrosis
7%
Graft Survival
9%
Hepatitis A
5%
Hepatitis B
8%
Hepatitis B Virus
9%
Hepatitis C
27%
Hepatitis C Virus
22%
Hepatocellular Carcinoma
25%
Immunosuppressive Treatment
9%
Infection
14%
Interferon
6%
Liver Cirrhosis
20%
Liver Disease
25%
Liver Failure
5%
Liver Graft
51%
Liver Injury
6%
Liver Transplantation
93%
Long Term Survival
5%
Lumbar Spine
6%
Model For End Stage Liver Disease Score
7%
Model for End-Stage Liver Disease
5%
Neoplasm
8%
Odds Ratio
5%
Paracetamol
13%
Peginterferon
6%
Primary Biliary Cirrhosis
17%
Primary Sclerosing Cholangitis
14%
Recurrent Disease
20%
Retransplantation
6%
Ribavirin
12%
Survival Rate
5%
Transcatheter Arterial Chemoembolization
7%
Virus
7%
Wilson's Disease
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Liver Failure
53%
Alpha Interferon
6%
Alpha2b Interferon
5%
Antiviral Drug
6%
Antiviral Therapy
5%
Chronic Hepatitis B
6%
Chronic Hepatitis C
17%
Ciclosporin
6%
Cohort Study
7%
Diseases
14%
End Stage Liver Disease
13%
Fibrosis
9%
Hepatitis A
5%
Hepatitis B
6%
Hepatitis B Virus
8%
Hepatitis C
31%
Hepatitis C Virus
24%
HIV
6%
Infection
15%
Inflammation
5%
Interferon
14%
Isoniazid
6%
Lamivudine
6%
Liver Cell Carcinoma
13%
Liver Cirrhosis
9%
Liver Disease
13%
Liver Failure
5%
Liver Injury
8%
microRNA
12%
Neoplasm
8%
Paracetamol
20%
Peginterferon
6%
Primary Biliary Cirrhosis
6%
Recurrent Disease
14%
Ribavirin
14%
Survival Rate
10%
Tacrolimus
6%
Tolerability
5%
Ursodeoxycholic Acid
6%
Virus Hepatitis
5%
Vitamin D-Binding Protein
6%
Wilson's Disease
5%